Prime Minister Manuel Valls, who vows to slash spending and lower taxes on business, could either sink or replace French President Hollande
Fiat Chrysler's police vehicle is a muscle car with cool features and the rear-wheel drive that many cops prefer
Its purchases alarm some right-wing conspiracy theorists, but in fact its ammo buying has been declining for years
Apple's iPhone sales last quarter exceed estimates, while iPad sales disappoint
Its revenue keeps rising, and it keeps adding more customers
Apple's new campus, designed by Stephen Behling and Sir Norman Foster, is raising some eyebrows
Amazon will be the first Internet-TV provider to stream HBO shows—if not new ones—by offering them on Instant Video and its Fire TV device
Expatriate professionals prepare for change when they set off to work abroad, but the real shock awaits their return to the corporation
Startup Casper bets it can sell foam-only bedding via a Web-only, direct-to-consumer business model
Founders: Dr. Samir Patel and Dr. David Guyer
VC Investment over the last four quarters: $37.47 million
Founded in 2007, the 15-employee Ophthotech is a biotech company developing treatments for age-related macular degeneration, a common cause of vision loss in older adults. The co-founders' prior venture, Eyetech, was acquired by OSI Pharmaceuticals (OSIP) in 2005 in a deal valued at $900 million.
Key to startup success: "[Our] in-depth understanding of the specific specialty pharma space, coupled with an experienced management and venture investors, has been key to our success."